Interventions for minimal change disease in adults with nephrotic syndrome-Reference-Cited by-同舟云学术

Interventions for minimal change disease in adults with nephrotic syndrome

Published:2022-03-01 Issue:3 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Azukaitis Karolis¹,Palmer Suetonia C²,Strippoli Giovanni FM³⁴,Hodson Elisabeth M⁴

Affiliation:

1. Clinic of Pediatrics, Institute of Clinical Medicine, Faculty of Medicine; Vilnius University; Vilnius Lithuania

2. Department of Medicine; University of Otago Christchurch; Christchurch New Zealand

3. Department of Emergency and Organ Transplantation; University of Bari; Bari Italy

4. Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference66 articles.

1. Controlled trial of prednisone in adult patients with the nephrotic syndrome;Black;British Medical Journal,1970

2. Adult minimal change nephropathy: experience of the collaborative study of glomerular disease;Coggins;Transactions of the American Clinical & Climatological Asoociation,1986

3. Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome;Eguchi;Nephrology Dialysis Transplantation,2010

4. Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome;Imbasciati;British Medical Journal Clinical Research Ed,1985

5. The combination of very low-dose prednisolone with cyclosporine as an initial treatment for minimal change nephrotic syndrome (MCNS) in adults [abstract no: F-PO1272];Inoue;Journal of the American Society of Nephrology,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relapsing nephrotic syndrome with acute renal failure following a unique episode of multiple bee stings: A case report;Clinical Case Reports;2024-06-27

2. Proximal tubular MBD2 promotes autophagy to drive the progression of AKI caused by vancomycin via regulation of miR‐597‐5p/S1PR1 axis;The FASEB Journal;2024-04-05

3. Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group;Nephrology Dialysis Transplantation;2024-02-10

4. External Validation of a Urinary Biomarker Risk Score for the Prediction of Steroid Responsiveness in Adults With Nephrotic Syndrome;Kidney International Reports;2023-11

5. Levamisole suppresses activation and proliferation of human T cells by the induction of a p53‐dependent DNA damage response;European Journal of Immunology;2023-08-31